Volume | 20,081 |
|
|||||
News | - | ||||||
Day High | 4.07 | Low High |
|||||
Day Low | 4.00 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
AirSculpt Technologies Inc | AIRS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
4.00 | 4.00 | 4.07 | 3.99 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
452 | 20,081 | US$ 4.03 | US$ 80,947 | - | 3.21 - 9.935 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
14:54:32 | 4 | US$ 4.03 | USD |
AirSculpt Technologies Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
230.84M | 57.42M | - | 195.92M | -4.48M | -0.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
AirSculpt Technologies News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIRS Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.09 | 4.6099 | 3.99 | 4.10 | 75,260 | -0.09 | -2.20% |
1 Month | 4.29 | 4.6635 | 3.21 | 4.01 | 98,796 | -0.29 | -6.76% |
3 Months | 5.95 | 6.3882 | 3.21 | 4.55 | 58,090 | -1.95 | -32.77% |
6 Months | 6.89 | 8.30 | 3.21 | 6.02 | 77,938 | -2.89 | -41.94% |
1 Year | 7.84 | 9.935 | 3.21 | 6.75 | 85,951 | -3.84 | -48.98% |
3 Years | 12.84 | 18.48 | 2.69 | 7.98 | 181,678 | -8.84 | -68.85% |
5 Years | 12.84 | 18.48 | 2.69 | 7.98 | 181,678 | -8.84 | -68.85% |
AirSculpt Technologies Description
AirSculpt Technologies Inc is a provider of body contouring procedures delivering a premium consumer experience. It provides a custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. Its mission is to generate the best results for patients. |